3.30 MB - Academy of Medicine of Malaysia

MANAGEMENT OF HIV INFECTION IN CHILDREN
222 Madhivanan P, Mothi SN, Kumarasamy N, et al. Clinical manifestations of HIV infected
children. Indian J Pediatr. 2003 Aug;70(8):615-620.
223 Sirisanthana V, Sirisanthana T. Disseminated Penicillium marneffei infection in human
immunodeficiency virus-infected children. Pediatr Infect Dis J. 1995 Nov;14(11):935-940.
224 Grimwade K, Swingler GH. Cotrimoxazole prophylaxis for opportunistic infections in
children with HIV infection. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003508.
225 Madhi SA, Petersen K, Khoosal M, et al. Reduced effectiveness of Haemophilus
influenzae type b conjugate vaccine in children with a high prevalence of human
immunodeficiency virus type 1 infection. Pediatr Infect Dis J. 2002 Apr;21(4):315-321.
226 Kaplan JE, Masur H & Holmes KK; USPHS; Infectious Disease Society of America.
Guidelines for preventing opportunistic infections among HIV-infected persons-2002.
Recommendations of the U.S. Public Health Service and the Infectious Diseases Society
of America. MMWR Recomm Rep. 2002 Jun 14;51(RR-8):1-52.
227 Evans JA, Gibb DM, Holland FJ, et al. Malignancies in UK children with HIV infection
acquired from mother to child transmission. Arch Dis Child. 1997;76(4):330-333.
228 Biggar RJ, Frisch M, Goedert JJ. Risk of cancer in children with AIDS. AIDS-Cancer Match
Registry Study Group. JAMA. 2000 Jul 12;284(2):205-9.
229 Fragoso YD, Andalaft R, Adamo AP, et al. Neurologic Manifestations of AIDS in Children
and Adolescents: A Review of Cases in Santos, Brazil. MedGenMed. 1999 Sep 24:E3.
230 Strauss J, Zilleruelo G, Abitbol C, et al. Human immunodeficiency virus nephropathy.
Pediatric Nephrology. April, 1993,7(2): 220-225.
231 Pardo V, Aldana M, Colton RM ,et al. Glomerular lesions in the acquired immunodeficiency
syndrome. Ann Intern Med. 1984; 101:429-434.
232 Starc TJ, Langston C, Goldfarb J, et al. Unexpected non-HIV causes of death in children
born to HIV-infected mothers.Pediatric Pulmonary and Cardiac Complications of Vertically
Transmitted HIV Infection Study Group. Pediatrics. 1999 Jul;104(1):e6.
233 Lipshultz SE, Easley KA, Orav EJ, et al. Cardiac dysfunction and mortality in HIV-infected
children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac
Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Circulation.
2000 Sep 26;102(13):1542-1548.
234 Jeena PM, Coovadia HM, Thula SA, et al. Persistent and chronic lung disease in HIV-1
infected and uninfected African children. AIDS. 1998;12(10):1185-1193.
235 Dufour V, Wislez M, Bergot E, et al. Improvement of symptomatic human immunodeficiency
virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral
therapy. Clin Infect Dis. 2003 May 15;36(10):e127-130.
236 Innes A L, Huang L, Nishimura S L. Resolution of lymphocytic interstitial pneumonitis in an
HIV infected adult after treatment with HAART. Transm Infect 2004;80:417-418.
237 Boon-Yasidhi V, Kottapat U, Durier Y, et al. Diagnosis disclosure in HIV-infected Thai
children. J Med Assoc Thai. 2005 Nov;88 Suppl 8:S100-105.
238 Wiener L, Mellins CA, Marhefka S, et al. Disclosure of an HIV diagnosis to children:
history, current research, and future directions. J Dev Behav Pediatr. 2007;28:155-166.
68